RxDoctor Payments Data

Justin Letourneau, PA

Physician Assistant · St Petersburg, FLNPI 1861710923

Payments from drug & device makers

$2,743in general payments, 2019–2025

Across 130 payments — averaging $21.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$690
  • Otsuka America Pharmaceutical, Inc.$349
  • Neurocrine Biosciences, Inc.$241
  • Noven Therapeutics, LLC$217
  • Axsome Therapeutics, Inc.$198
  • Takeda Pharmaceuticals U.S.A., Inc.$185
  • plus $864 from 11 others

What the payments were for

  • Food & beverage$2,743100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,743 in reported general payments places this provider in the 80th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$29,393
Medicare patients
66
Services billed
775

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole15$24,193
TrintellixVortioxetine Hydrobromide19$10,259
Desvenlafaxine Succinate ErDesvenlafaxine Succinate200$9,036
Aripiprazole236$5,338
Mirtazapine107$2,445
Duloxetine Hcl139$2,321
Lamotrigine187$2,140
Bupropion XlBupropion Hcl127$1,975
Quetiapine Fumarate107$1,776
Clonazepam180$1,631
Trazodone Hcl202$1,573
Oxcarbazepine13$1,251
Alprazolam279$1,079
Venlafaxine Hcl ErVenlafaxine Hcl56$1,004
Atomoxetine Hcl11$955

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$349$24,19315 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$185$10,25919 claims
Almatica Pharma LLCSertraline Hcl$130$59293 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in St Petersburg

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →